FDA
approval
· 2021-04-05
FDA Approved: NEOSTIGMINE METHYLSULFATE — Original Application (Meitheal Pharmaceuticals Inc.)
Summary
The FDA approved a generic version of neostigmine methylsulfate from Meitheal Pharmaceuticals Inc. for its approved uses in treating myasthenia gravis and rever…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
ORIG AP for NEOSTIGMINE METHYLSULFATE (NEOSTIGMINE METHYLSULFATE)